Skip to content
Bamboo WorksBamboo Works
Search
Register / Sign in
MSCI China | MSCI China Small-Cap | Hang Seng Index | Hang Seng China Enterprise
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

Recombinant poliomyelitis vaccine

Founded in 2009 as a vaccine manufacturer, CanSino was listed on the Hong Kong Stock Exchange in March 2019 and on the Shanghai STAR Market in August 2020.

FAST NEWS: CanSino’s quarterly revenue rises, but loss also widens

The Latest: CanSino Biologics Inc. (6185.HK; 688185.SH) reported Monday its revenue rose 13.7% year-on-year to about 114 million yuan ($15.7 million) in the first quarter, while its net loss widened 21.9% to…
April 30, 2024
6185.HK 688185.SHG
CanSino Biologics announced on Tuesday it has entered into a grant agreement with the Bill & Melinda Gates Foundation, which will provide over $2 million to support development of the company’s recombinant poliomyelitis vaccine based on one of its virus-like particles.

FAST NEWS: CanSino receives Gates Foundation grant to develop polio vaccine

The latest: CanSino Biologics Inc. (6185.HK; 688185.SH) announced on Tuesday it has entered into a grant agreement with the Bill & Melinda Gates Foundation, which will provide over $2 million to support…
October 25, 2023
6185.HK 688185.SHG

Recent Articles

Founded in 2009 as a vaccine manufacturer, CanSino was listed on the Hong Kong Stock Exchange in March 2019 and on the Shanghai STAR Market in August 2020.
April 30, 2024

FAST NEWS: CanSino’s quarterly revenue rises, but loss also widens

6185.HK 688185.SHG
October 25, 2023

FAST NEWS: CanSino receives Gates Foundation grant to develop polio vaccine

6185.HK 688185.SHG

RECENT ARTICLES

  1. Clover Biopharmaceuticals Ltd. faces a potentially damaging fight
    April 3, 2025
    Dispute over Covid vaccines casts doubt on Clover Bio recovery
    2197.HK
  2. January 20, 2025
    Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising
    ZYBT.US
  3. March 25, 2025
    Everest Medicines drives growth with AI-powered mRNA pipeline
    1952.HK
  4. January 16, 2025
    WuXi Biologics sells vaccine plant as new U.S. law looms
    2269.HK
  5. November 25, 2024
    NaaS drives into third quarter with first-ever quarterly non-IFRS profit
    NAAS.US
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Audio/Video
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • AI/Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2021 - 2025 Bamboo Works. All rights reserved.